Italian GIDS-PD Scale Validation for Parkinson's
Part of Brain & nervous system clinical trials.
This trial aims to translate and validate an Italian version of a scale that measures functional independence in people with Parkinson's disease. By participating, you will help ensure the scale is accurate and useful for Italian-speaking patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with Parkinson's disease by a neurologist using standard criteria.
- You must be a native Italian speaker or understand Italian well.
- You must be mentally and physically able to understand and sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses advanced tools to better diagnose and treat Parkinson's disease and Alzheimer's disease. It aims to personalize care based on your specific symptoms and biomarkers.
This trial tests a remote way to assess people newly diagnosed with Parkinson's disease, to help monitor their condition and guide care.
This study is testing a set of physical tests (called the Short Physical Performance Battery) to see if they are a good way to measure physical function in people with Parkinson's disease. By participating, you help doctors better understand how to assess mobility and balance in Parkinson's, which could improve future care.
This study looks at how people with Parkinson’s adapt their movements and how their brain sensorimotor system works. It may help researchers improve understanding of Parkinson’s and refine movement-focused therapies.
This trial tests an investigational drug called GT-02287 in people with early-stage Parkinson's disease (diagnosed within the last 7 years). The goal is to see if it is safe and how the body processes it, with a special focus on people with certain genetic changes (GBA1 mutations) that may be linked to Parkinson's.
This study follows people with Parkinson’s disease, certain Parkinson-like conditions, and some people at higher risk. It helps researchers learn how these illnesses start and progress, which may lead to better earlier detection and care.
Hear when a new PARKINSON DISEASE (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.